NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
FORT MYERS, Fla., October 15, 2024--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its third quarter 2024 financial ...